• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
Roundup's list of ingredients, including Glyphosate, is seen on a bottle set for sale in a store in Manhattan, New York City, U.S., June 30, 2022. Andrew Kelly/
Roundup's list of ingredients, including Glyphosate, is seen on a bottle set for sale in a store in Manhattan, New York City, U.S., June 30, 2022. Andrew Kelly/
Home
Business
Healthcare & Pharmaceuticals

EU to renew herbicide glyphosate approval for 10 years

November 16th, 2023 | 10:13 AM BUSINESS Healthcare & Pharmaceuticals 2

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Multistate salmonella infections climb to 431, US CDC says
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder
Michigan confirms human case of rare mosquito-borne disease
US FDA approves Regeneron's rare bone disorder drug
By Philip Blenkinsop, Sudip Kar-Gupta

The European Union will extend glyphosate's authorisation for 10 years, even though its member states failed to agree over the active ingredient in Bayer AG's (BAYGn.DE) Roundup weedkiller.

Glyphosate has proved divisive since the World Health Organization's cancer research agency concluded in 2015 that it was probably carcinogenic to humans. Other agencies around the world, including the U.S. Environmental Protection Agency (EPA) and EU agencies, have classified it as non-carcinogenic.

The European Commission said on Thursday it would renew glyphosate's approval based on European Food Agency and European Chemicals Agency safety assessments and subject to new conditions and restrictions, such as maximum application rates.

Bayer welcomed the EU executive's decision, which was condemned by environmental groups including Greenpeace.

"This reauthorisation allows us to continue to provide important integrated weed management technology to farmers across the European Union," Bayer said in a statement.

The German company, which acquired Roundup through its $63 billion purchase of Monsanto in 2018, faces thousands of cancer lawsuits from plaintiffs across the United States.

Glyphosate has been widely used for decades by farmers and in other uses such as to clear weeds from railways lines.

The Commission had proposed extending authorisation by 10 years and sought approval from the EU's 27 member countries.

A more substantial "qualified majority" had been required either to support of block the proposal, but on Thursday and a month ago, the voting did not clear this hurdle.

Under EU rules, the Commission had to take a decision on authorisation which was due to expire on Dec. 15.

French pro-environmental farming group Confederation Paysanne called the decision and the approval process "scandalous". France was among a number of countries to abstain.

Greenpeace said it was outraged by the decision, which was contrary to numerous opinions of scientists on glyphosate's probable negative effects on human health and the environment.

Agriculture without glyphosate was possible, it said, and public policies should help farmers to phase it out. Farming group Copa and Cogeca said there was no equivalent alternative.

Individual EU countries will remain responsible for authorising plant protection products containing glyphosate.

  • Topic
  • EU
  • HEALTH/GLYPHOSATE (UPDATE 2, PIX)
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Multistate salmonella infections climb to 431, US CDC says

Related Posts

Healthcare & Pharmaceuticals
August 19th, 2026

Multistate salmonella infections climb to 431, US CDC says

Healthcare & Pharmaceuticals
August 19th, 2026

Ultragenyx's gene therapy wins first FDA approval for rare metabolic dis...

Healthcare & Pharmaceuticals
August 19th, 2026

Michigan confirms human case of rare mosquito-borne disease

Healthcare & Pharmaceuticals
August 19th, 2026

US FDA approves Regeneron's rare bone disorder drug

Healthcare & Pharmaceuticals
August 19th, 2026

West Nile virus outbreak kills four in North Macedonia 

Healthcare & Pharmaceuticals
August 19th, 2026

Moderna shares double as cancer vaccine data rekindles investor hopes

The Wire
Aug 20th 2 h ago
Investigates

In China, rocket launches fuel tourism and space-age dreams

Aug 19th 3 h ago
Asia Pacific

Japan exports rise 23.2% year/year in July

Aug 19th 3 h ago
Baseball

D-backs score twice in 10th, salvage series finale at Red S...

Aug 19th 4 h ago
Government

US tells schools not to alter discipline policies to reduce...

Aug 19th 4 h ago
Transactional

China tax crackdown forces wealthy investors to assess thei...

TRENDING ON FINANCETIME
Aug 19th, 2026 Tennis

Paul ousts top seed Zverev to reach Cincinnati quarter-finals

Aug 19th, 2026 Litigation

AIA Group's first-half new business value rises 10%

Aug 19th, 2026 Energy

Brazil's largest thermal power plant shut down after equipment failure

Aug 19th, 2026 United Kingdom

Key moments in Prince Harry and Meghan's six years in California

Aug 19th, 2026 Sports

Orioles reinstate C Samuel Basallo (shoulder) to active roster

Markets-Sectors
ENERGY -0.16%
FINANCIALS -0.62%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT